Deal Team

Finance
Corporate
Executive Compensation and Benefits
Tax

Abbott Laboratories in its revolving credit facility

On January 29, 2024, Abbott Laboratories entered into a five-year $5.0 billion unsecured revolving credit facility with the lenders party thereto and JPMorgan Chase Bank, N.A. as administrative agent. 

Wachtell, Lipton, Rosen & Katz is serving as legal advisor to Abbott. 

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.